Registry for Hypoparathyroidism Wuerzburg
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Wuerzburg
About this trial
Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a standardized interview as well as blood sampling and examinations such as echocardiography and renal ultrasound are performed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age of 18
chronic hypoparathyroidism (>12 months) under established therapy or chronic pseudohypoparathyroidism (>12 months) under established therapy
written informed consent
Disqualifiers
age <18 years
no detailed documentation of hypo- or pseudohypoparathyroidism
Trial population
patients with chronic hypo- and pseudohypoparathyroidism
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Comorbidites
Comorbidities such as renal diseases, cardiovascular disease, psychiatric diseases under treatment
Time frame
15 years2
Subjective health status
Assessment of the subjective health status by standardized quality of life (QoL) questionnaires (e.g. short form-36, Patient Health Questionnaire 28)
Time frame
15 yearsSecondary outcomes
1
Hypocalcemic and hypercalcemic events
documentation of frequency of hypocalcemia under standard treatment
Time frame
15 years2
Mortality
Time frame
15 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov